Clinical trial
Randomized, Double Blinded, Placebo Control Clinical Trial of Pandemic Influenza…
NCT00356798 · Sinovac Biotech Co., Ltd, Industry · Completed
Key facts
| NCT number | NCT00356798 |
|---|---|
| Title | Randomized, Double Blinded, Placebo Control Clinical Trial of Pandemic Influenza Inactive Vaccine on Healthy Subjects |
| Official title | The Phase-I Clinical Trial Protocol for the Pandemic Inactivated Influenza Vaccine |
| Lead sponsor | Sinovac Biotech Co., Ltd, Industry |
| Collaborators | Ministry of Science and Technology of the People´s Republic of China |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Influenza |
| Intervention type | Biological |
| Interventions | an inactivated whole virion H5N1 vaccine, adjuvanted |
| Enrollment | 120 |
| Start date | Dec 1, 2005 |
| Completion | Apr 1, 2006 |
| First posted | Jul 26, 2006 |
| Last update posted | Nov 9, 2007 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: